| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 03/24/2011 | US20110071143 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | US20110071141 Pesticidial Condensed-Ring Aryl Compounds |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110070298 Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance |
| 03/24/2011 | US20110070296 Topical compositions and methods for utilizing peptides containing lipid-modified cysteine-containing peptides |
| 03/24/2011 | US20110070250 Therapeutical Composition Containing Dentritic Cells and use Thereof |
| 03/24/2011 | US20110070224 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 03/24/2011 | CA2773832A1 Compounds useful against kinetoplastideae parasites |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298325A1 Combinations comprising anti-adhesive and prebiotic carbohydrates |
| 03/23/2011 | EP2200991B1 Antibacterial agents |
| 03/23/2011 | CN101990438A Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 03/23/2011 | CN101988069A Eimeria tenella heat shock protein 60 gene as well as cloning, expression and application thereof |
| 03/23/2011 | CN101987847A Novel heterocyclic NF-kB inhibitors |
| 03/23/2011 | CN101987108A Compound injection for repelling internal and external parasites of animal bodies and preparation method thereof |
| 03/23/2011 | CN101485750B Amygdalus pedunculata leaf extract and use thereof |
| 03/23/2011 | CN101401784B Sodium closantel injection formulation and preparation method thereof |
| 03/22/2011 | US7910564 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 03/22/2011 | US7910114 Methods of treating infectious diseases |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 03/17/2011 | WO2011031317A2 Vaccine for control of trypanosoma cruzi infection and chagas disease |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065733 Mapk/erk kinase inhibitors |
| 03/17/2011 | US20110065704 Compounds for modulating rna binding proteins and uses therefor |
| 03/17/2011 | US20110065698 Novel protein kinase modulators |
| 03/17/2011 | US20110064768 Immunogenic Compositions |
| 03/17/2011 | US20110064718 Pesticidal and Antiparasitic Compositions |
| 03/17/2011 | US20110061649 Device and method for treating respiratory and other diseases |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295419A2 Substituted tetracycline compounds |
| 03/16/2011 | EP2295404A2 Substituted tetracycline compounds |
| 03/16/2011 | EP2057165B1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | EP1326633B1 Composition comprising immunogenic microparticles |
| 03/16/2011 | CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives |
| 03/16/2011 | CN101985468A SJ16 recombinant protein and application thereof in preparing schistosomiasis vaccine, diagnostic reagent and therapeutic drug |
| 03/16/2011 | CN101985432A 3-Fmoc amino-3-(3-nitro-4-fluophenyl) propionic acid and preparation method thereof |
| 03/16/2011 | CN101984970A Dihydroartemisinin piperaquine phosphate tablets and preparation process thereof |
| 03/16/2011 | CN101984958A Nanoscale albendazole micropowder and preparation method thereof |
| 03/16/2011 | CN101485749B Effervescent tablets for women as well as preparation method and application thereof |
| 03/15/2011 | US7906535 High concentration topical insecticides containing pyrethroids |
| 03/15/2011 | US7906128 Controlling parasites in animals by administerinng sodium channel activators |
| 03/15/2011 | CA2429134C A method for generating genetically altered antigens |
| 03/10/2011 | WO2011027333A1 Granulated anthelmintic preparations and delivery systems |
| 03/10/2011 | WO2010108164A3 Novel anti-parasitic compounds |
| 03/10/2011 | US20110060023 Parasiticidal formulation |
| 03/10/2011 | US20110059988 Isoxazoline compositions and their use as antiparasitics |
| 03/10/2011 | US20110059934 Compounds and compositions useful for the treatment of parasitic diseases |
| 03/10/2011 | US20110059147 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 03/10/2011 | US20110059120 Glucan-based vaccines |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059042 Substituted il-15 |
| 03/10/2011 | CA2777225A1 Granulated anthelmintic preparations and delivery systems |
| 03/10/2011 | CA2772198A1 Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292652A2 Interferons uses and compositions related thereto |
| 03/09/2011 | EP2292632A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/09/2011 | EP2291394A1 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 03/09/2011 | EP1824845B1 1-arylpyrazoles and their use as pesticides |
| 03/08/2011 | US7902232 Substituted arylpyrazoles |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2426247C Particle formation methods and their products |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011022798A1 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same |
| 03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
| 03/03/2011 | US20110052737 Topical skin formulations comprising botanical extracts |
| 03/03/2011 | US20110052584 Method of enhancement of cytotoxicity in antibody mediated immune responses |
| 03/03/2011 | US20110052525 Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid |
| 03/03/2011 | DE102009038950A1 Neue antiparasitäre Kombination von Wirkstoffen New antiparasitic combination of active ingredients |
| 03/03/2011 | DE102009038949A1 Neue Verwendung von heterocyclisch substituierten 1,2,4-Triazindionen New use of heterocyclic substituted 1,2,4-triazinediones |
| 03/03/2011 | CA2772085A1 Compounds that treat malaria and prevent malaria transmission |
| 03/03/2011 | CA2771044A1 Aralkyl benzyl ethers compounds, process for preparation thereof, intermediate compounds, use of such compounds, methods of treatment and/or prevention, pharmaceutical compositionand medicine containing the same |
| 03/02/2011 | EP2289549A2 Immunoconjugates for treating cancer |
| 03/02/2011 | EP2288359A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 03/02/2011 | EP1638552B1 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer |
| 03/02/2011 | CN101982458A 3-amino-3-arylpropionic acid and preparation method thereof |
| 02/24/2011 | WO2011022337A1 Boron-containing small molecules as antiprotozoal agents |
| 02/24/2011 | US20110046579 Use of a 1-n-(halo-3-pyridylmethyl)-n-methylamino-1-alkylamino-2-nitroethylene derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites |
| 02/24/2011 | US20110046233 Gossypol derivatives, production method thereof and uses of same |
| 02/24/2011 | US20110046155 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 02/24/2011 | US20110046142 Antibiotic compounds |
| 02/24/2011 | US20110046125 Method for treating infections |
| 02/24/2011 | US20110046072 Solid pharmaceutical formulation with delayed release |
| 02/24/2011 | US20110046044 Use of a cysteine protease of Plasmodium vivax |
| 02/24/2011 | US20110045100 Antimalarial Quinolines and Methods of Use Thereof |
| 02/24/2011 | US20110045049 Immunomodulating compositions and methods of use |
| 02/24/2011 | US20110045016 Utilization of recombinant influenza viruses and modified vaccinia ankara virus (mva) with genes that encode for the toxoplasma gondii sag1 and sag2 surface proteins, as vaccines against toxoplasmosis |
| 02/24/2011 | US20110045014 Acceleration agent of calcium absorption |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110044976 Humanized antibodies |
| 02/24/2011 | US20110044946 Genetec regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 02/24/2011 | CA2769415A1 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| 02/23/2011 | EP2287150A2 Substituted tetracycline compounds |
| 02/23/2011 | EP2287148A2 Substituted tetracycline compounds |
| 02/23/2011 | EP2287140A2 Substituted tetracycline compounds |
| 02/23/2011 | EP2286876A1 Parasiticidal composition |
| 02/23/2011 | EP2286812A1 Solubilized topoisomerase poisons |
| 02/23/2011 | EP2286663A2 Methods and compositions for treating ectoparasite infestation |